ARTICLE | Clinical News
Topical dexchlorpheniramine antihistamine that uses lipid solubility to enhance skin penetration: Began Phase IB/II dose-escalation trial
February 6, 1995 8:00 AM UTC
Arcturus Pharmaceutical Corp., Woburn, Mass. Product: Topical dexchlorpheniramine antihistamine that uses lipid solubility to enhance skin penetration Indication: Treat pruritis (itch) in patients wit...